drugset
drugset / Trial / NCT04110860

Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel

NCT04110860 ↗

Phase 2 Completed 30 enrolled Sara Botros
RandomizedParallel-groupDouble-blindTreatment

Summary

Clinical study for the developed voriconazole self nano emulsifying drug delivery system intermediate gel was conducted on 30 patients with tinea versicolor infection.

Timeline

Start
2018-02-15
Primary completion
2018-06-20
Completion
2018-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Voriconazole Small molecule — Topical

Indications

pityriasis versicolor